TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs3132528
log Bayes Factor = 56.4671
Chromosome 6   position 31,131,569  (GRCh37) Explore rs3132528 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
E10.9 Without complications
0.000 0.000 1.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
E83.1 Disorders of iron metabolism
0.999 0.001 0.000
E11.9 Without complications
0.000 0.001 0.999
E11 Non-insulin-dependent diabetes mellitus
0.000 0.002 0.998
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.004 0.996
E05.9 Thyrotoxicosis, unspecified
0.000 0.004 0.996
E78.0 Pure hypercholesterolaemia
0.000 0.017 0.983
G35 Multiple sclerosis
0.981 0.019 0.000
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.021 0.979
E70-E90 Metabolic disorders
0.000 0.026 0.974
L40 Psoriasis
0.000 0.055 0.945
E14 Unspecified diabetes mellitus
0.000 0.086 0.914
E11.0 With coma
0.000 0.123 0.877
L40.5 Arthropathic psoriasis
0.000 0.123 0.877
E78.8 Other disorders of lipoprotein metabolism
0.000 0.139 0.861
E07 Other disorders of thyroid
0.000 0.162 0.838
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.165 0.835
E10.3 With ophthalmic complications
0.000 0.171 0.829
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.184 0.816
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.194 0.806
E14.3 With ophthalmic complications
0.000 0.196 0.804
E03.8 Other specified hypothyroidism
0.000 0.199 0.801
E78.2 Mixed hyperlipidaemia
0.000 0.202 0.798
L40.0 Psoriasis vulgaris
0.000 0.204 0.796
L40.8 Other psoriasis
0.000 0.210 0.790
E11.1 With ketoacidosis
0.000 0.213 0.787
E79 Disorders of purine and pyrimidine metabolism
0.000 0.239 0.761
E74 Other disorders of carbohydrate metabolism
0.000 0.244 0.756
E10.6 With other specified complications
0.000 0.248 0.752
E10.8 With unspecified complications
0.000 0.251 0.749
K90 Intestinal malabsorption
0.000 0.257 0.743
E14.9 Without complications
0.000 0.258 0.742
E78.4 Other hyperlipidaemia
0.000 0.260 0.740
G35-G37 Demyelinating diseases of the central nervous system
0.739 0.261 0.000
E78.1 Pure hyperglyceridaemia
0.000 0.262 0.738
E07.9 Disorder of thyroid, unspecified
0.000 0.265 0.735
E11.2 With renal complications
0.000 0.266 0.734
E13 Other specified diabetes mellitus
0.000 0.271 0.729
E14.5 With peripheral circulatory complications
0.000 0.279 0.720
L40.1 Generalised pustular psoriasis
0.000 0.280 0.720
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.283 0.717
E10.7 With multiple complications
0.000 0.283 0.717
E11.7 With multiple complications
0.000 0.284 0.716
E05.5 Thyroid crisis or storm
0.000 0.286 0.714
E05.4 Thyrotoxicosis factitia
0.000 0.286 0.714
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.286 0.714
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.286 0.714
E10.0 With coma
0.000 0.292 0.708
E78.3 Hyperchylomicronaemia
0.000 0.298 0.702
E78.6 Lipoprotein deficiency
0.000 0.298 0.702
E40-E46 Malnutrition
0.000 0.300 0.700
E77 Disorders of glycoprotein metabolism
0.000 0.301 0.698
E76 Disorders of glycosaminoglycan metabolism
0.000 0.301 0.698
E72 Other disorders of amino-acid metabolism
0.000 0.301 0.698
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.301 0.698
E70 Disorders of aromatic amino-acid metabolism
0.000 0.301 0.698
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.301 0.698
E10.1 With ketoacidosis
0.000 0.303 0.697
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.311 0.689
E83 Disorders of mineral metabolism
0.654 0.315 0.032
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.318 0.682
E14.4 With neurological complications
0.000 0.320 0.680
G37 Other demyelinating diseases of central nervous system
0.678 0.322 0.000
L40.2 Acrodermatitis continua
0.000 0.323 0.677
E84 Cystic fibrosis
0.000 0.328 0.672
L40.4 Guttate psoriasis
0.000 0.329 0.671
E16 Other disorders of pancreatic internal secretion
0.000 0.333 0.667
E78.5 Hyperlipidaemia, unspecified
0.000 0.333 0.667
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.340 0.660
E14.1 With ketoacidosis
0.000 0.343 0.657
E14.7 With multiple complications
0.000 0.344 0.656
E14.0 With coma
0.000 0.344 0.656
E14.2 Withrenal complications
0.000 0.352 0.648
E14.6 With other specified complications
0.000 0.354 0.646
E80.4 Gilbert's syndrome
0.000 0.358 0.642
E80.6 Other disorders of bilirubin metabolism
0.000 0.359 0.641
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.366 0.633
E03.1 Congenital hypothyroidism without goitre
0.000 0.367 0.633
E11.8 With unspecified complications
0.000 0.378 0.622
E80.2 Other porphyria
0.000 0.378 0.622
E05.8 Other thyrotoxicosis
0.000 0.379 0.621
G37.9 Demyelinating disease of central nervous system, unspecified
0.619 0.381 0.000
E14.8 With unspecified complications
0.000 0.385 0.615
E10.2 With renal complications
0.000 0.389 0.611
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.391 0.609
E07.1 Dyshormogenetic goitre
0.000 0.399 0.601
E07.0 Hypersecretion of calcitonin
0.000 0.399 0.601
K90.9 Intestinal malabsorption, unspecified
0.000 0.399 0.601
E10.5 With peripheral circulatory complications
0.000 0.400 0.600
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.415 0.585
E80.5 Crigler-Najjar syndrome
0.000 0.415 0.585
E80.3 Defects of catalase and peroxydase
0.000 0.415 0.585
E80.0 Hereditary erythropoietic porphyria
0.000 0.415 0.585
E80.1 Porphyria cutanea tarda
0.000 0.421 0.579
E15 Nondiabetic hypoglycaemic coma
0.000 0.422 0.578
E83.3 Disorders of phosphorus metabolism
0.563 0.428 0.009
E88 Other metabolic disorders
0.000 0.429 0.571
E07.8 Other specified disorders of thyroid
0.000 0.430 0.570
G36 Other acute disseminated demyelination
0.567 0.433 0.000
L40-L45 Papulosquamous disorders
0.000 0.436 0.564
E73 Lactose intolerance
0.000 0.438 0.562
E13.9 Without complications
0.000 0.443 0.557
L40.3 Pustulosis palmaris et plantaris
0.000 0.445 0.554
G37.8 Other specified demyelinating diseases of central nervous system
0.547 0.453 0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.454 0.546
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.454 0.546
E79.1 Lesch-Nyhan syndrome
0.000 0.454 0.546
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.458 0.542
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.458 0.542
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.458 0.542
E74.2 Disorders of galactose metabolism
0.000 0.458 0.542
E74.1 Disorders of fructose metabolism
0.000 0.458 0.542
E16.2 Hypoglycaemia, unspecified
0.000 0.462 0.538
K90.3 Pancreatic steatorrhoea
0.000 0.467 0.532
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.467 0.532
K90.1 Tropical sprue
0.000 0.467 0.532
K90.8 Other intestinal malabsorption
0.000 0.469 0.531
E83.9 Disorder of mineral metabolism, unspecified
0.507 0.473 0.020
C83.3 Large cell (diffuse)
0.000 0.473 0.527
E13.8 With unspecified complications
0.000 0.477 0.523
E13.7 With multiple complications
0.000 0.477 0.523
E13.6 With other specified complications
0.000 0.477 0.523
E13.5 With peripheral circulatory complications
0.000 0.477 0.523
E13.4 With neurological complications
0.000 0.477 0.523
E13.2 With renal complications
0.000 0.477 0.523
E13.1 With ketoacidosis
0.000 0.477 0.523
E13.0 With coma
0.000 0.477 0.523
E16.1 Other hypoglycaemia
0.000 0.480 0.520
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
E11.5 With peripheral circulatory complications
0.000 0.494 0.506
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.498 0.502
E45 Retarded development following protein-energy malnutrition
0.000 0.498 0.502
E43 Unspecified severe protein-energy malnutrition
0.000 0.498 0.502
E42 Marasmic kwashiorkor
0.000 0.498 0.502
E41 Nutritional marasmus
0.000 0.498 0.502
E40 Kwashiorkor
0.000 0.498 0.502
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.499 0.501
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.499 0.501
E70.3 Albinism
0.000 0.499 0.501
E70.2 Disorders of tyrosine metabolism
0.000 0.499 0.501
E70.1 Other hyperphenylalaninaemias
0.000 0.499 0.501
E70.0 Classical phenylketonuria
0.000 0.499 0.501
E71.3 Disorders of fatty-acid metabolism
0.000 0.499 0.501
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.499 0.501
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.499 0.501
E71.0 Maple-syrup-urine disease
0.000 0.499 0.501
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.499 0.501
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.499 0.501
E72.5 Disorders of glycine metabolism
0.000 0.499 0.501
E72.4 Disorders of ornithine metabolism
0.000 0.499 0.501
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.499 0.501
E72.2 Disorders of urea cycle metabolism
0.000 0.499 0.501
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.499 0.501
E72.0 Disorders of amino-acid transport
0.000 0.499 0.501
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.499 0.501
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.499 0.501
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.499 0.501
E76.2 Other mucopolysaccharidoses
0.000 0.499 0.501
E76.1 Mucopolysaccharidosis, type II
0.000 0.499 0.501
E76.0 Mucopolysaccharidosis, type I
0.000 0.499 0.501
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.499 0.501
E77.8 Other disorders of glycoprotein metabolism
0.000 0.499 0.501
E77.1 Defects in glycoprotein degradation
0.000 0.499 0.501
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.499 0.501
E13.3 With ophthalmic complications
0.000 0.504 0.496
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.504 0.496
E83.8 Other disorders of mineral metabolism
0.469 0.508 0.023
E83.2 Disorders of zinc metabolism
0.469 0.508 0.023
E83.0 Disorders of copper metabolism
0.469 0.508 0.023
E75.6 Lipid storage disorder, unspecified
0.000 0.511 0.489
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.511 0.489
E75.3 Sphingolipidosis, unspecified
0.000 0.511 0.489
E75.2 Other sphingolipidosis
0.000 0.511 0.489
E75.1 Other gangliosidosis
0.000 0.511 0.489
E75.0 GM2 gangliosidosis
0.000 0.511 0.489
G37.5 Concentric sclerosis [Balo]
0.486 0.514 0.000
G37.4 Subacute necrotising myelitis
0.486 0.514 0.000
G37.2 Central pontine myelinolysis
0.486 0.514 0.000
G37.1 Central demyelination of corpus callosum
0.486 0.514 0.000
G37.0 Diffuse sclerosis
0.486 0.514 0.000
E10.4 With neurological complications
0.000 0.514 0.486
E46 Unspecified protein-energy malnutrition
0.000 0.515 0.485
E84.8 Cystic fibrosis with other manifestations
0.000 0.518 0.482
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.518 0.482
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.518 0.482
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.519 0.481
E74.0 Glycogen storage disease
0.000 0.519 0.481
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.521 0.478
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.521 0.478
E16.4 Abnormal secretion of gastrin
0.000 0.521 0.478
E16.3 Increased secretion of glucagon
0.000 0.521 0.478
E11.6 With other specified complications
0.000 0.526 0.474
E75.5 Other lipid storage disorders
0.000 0.528 0.472
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.467 0.533 0.000
L43 Lichen planus
0.000 0.535 0.465
E84.9 Cystic fibrosis, unspecified
0.000 0.545 0.455
E88.2 Lipomatosis, not elsewhere classified
0.000 0.554 0.445
G36.0 Neuromyelitis optica [Devic]
0.445 0.555 0.000
L42 Pityriasis rosea
0.000 0.561 0.439
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.001 0.570 0.429
E11.4 With neurological complications
0.000 0.575 0.425
E85 Amyloidosis
0.001 0.575 0.425
L43.9 Lichen planus, unspecified
0.000 0.581 0.419
E20-E35 Disorders of other endocrine glands
0.000 0.585 0.415
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.589 0.411
E88.9 Metabolic disorder, unspecified
0.000 0.590 0.409
E88.8 Other specified metabolic disorders
0.000 0.590 0.409
G36.9 Acute disseminated demyelination, unspecified
0.407 0.593 0.000
G36.8 Other specified acute disseminated demyelination
0.407 0.593 0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.407 0.593 0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.594 0.406
L44 Other papulosquamous disorders
0.000 0.596 0.404
L41 Parapsoriasis
0.000 0.596 0.404
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.596 0.404
E88.3 Tumour lysis syndrome
0.000 0.596 0.404
E73.8 Other lactose intolerance
0.000 0.597 0.403
E73.1 Secondary lactase deficiency
0.000 0.597 0.403
E73.0 Congenital lactase deficiency
0.000 0.597 0.403
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.604 0.395
E06 Thyroiditis
0.000 0.617 0.382
E83.4 Disorders of magnesium metabolism
0.367 0.622 0.011
E89.4 Postprocedural ovarian failure
0.000 0.623 0.377
E28 Ovarian dysfunction
0.000 0.628 0.372
E44.1 Mild protein-energy malnutrition
0.000 0.640 0.360
E44.0 Moderate protein-energy malnutrition
0.000 0.640 0.360
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.644 0.355
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.644 0.355
E89.5 Postprocedural testicular hypofunction
0.000 0.644 0.355
E89.1 Postprocedural hypoinsulinaemia
0.000 0.644 0.355
E28.2 Polycystic ovarian syndrome
0.000 0.649 0.351
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.651 0.349
C83 Diffuse non-Hodgkin's lymphoma
0.005 0.657 0.337
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.661 0.339
E89.3 Postprocedural hypopituitarism
0.000 0.661 0.339
L43.3 Subacute (active) lichen planus
0.000 0.666 0.334
L43.2 Lichenoid drug reaction
0.000 0.666 0.334
L43.1 Bullous lichen planus
0.000 0.666 0.334
L43.0 Hypertrophic lichen planus
0.000 0.666 0.334
E24 Cushing's syndrome
0.000 0.668 0.332
E23 Hypofunction and other disorders of pituitary gland
0.000 0.671 0.329
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.001 0.671 0.328
E65-E68 Obesity and other hyperalimentation
0.000 0.675 0.325
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.008 0.677 0.316
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.678 0.322
C85.1 B-cell lymphoma, unspecified
0.000 0.678 0.322
E21.3 Hyperparathyroidism, unspecified
0.000 0.688 0.312
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.002 0.689 0.309
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.693 0.307
E85.2 Heredofamilial amyloidosis, unspecified
0.001 0.695 0.304
E85.1 Neuropathic heredofamilial amyloidosis
0.001 0.695 0.304
E85.0 Nonneuropathic heredofamilial amyloidosis
0.001 0.695 0.304
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.703 0.297
E32 Diseases of thymus
0.000 0.703 0.297
E31 Polyglandular dysfunction
0.000 0.703 0.297
E30 Disorders of puberty, not elsewhere classified
0.000 0.703 0.297
E25 Adrenogenital disorders
0.000 0.703 0.297
E83.5 Disorders of calcium metabolism
0.294 0.703 0.003
E89.2 Postprocedural hypoparathyroidism
0.000 0.710 0.290
L41.9 Parapsoriasis, unspecified
0.000 0.710 0.290
L41.8 Other parapsoriasis
0.000 0.710 0.290
L41.5 Retiform parapsoriasis
0.000 0.710 0.290
L41.4 Large plaque parapsoriasis
0.000 0.710 0.290
L41.3 Small plaque parapsoriasis
0.000 0.710 0.290
L41.2 Lymphomatoid papulosis
0.000 0.710 0.290
L41.1 Pityriasis lichenoides chronica
0.000 0.710 0.290
L41.0 Pityriasis lichenoides et varioliformis acuta
0.000 0.710 0.290
L44.9 Papulosquamous disorder, unspecified
0.000 0.710 0.290
L44.8 Other specified papulosquamous disorders
0.000 0.710 0.290
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.000 0.710 0.290
L44.3 Lichen ruber moniliformis
0.000 0.710 0.290
L44.2 Lichen striatus
0.000 0.710 0.290
L44.1 Lichen nitidus
0.000 0.710 0.290
L44.0 Pityriasis rubra pilaris
0.000 0.710 0.290
E85.8 Other amyloidosis
0.001 0.710 0.289
E85.9 Amyloidosis, unspecified
0.001 0.716 0.283
E50-E64 Other nutritional deficiencies
0.000 0.718 0.282
E26 Hyperaldosteronism
0.000 0.722 0.277
E06.5 Other chronic thyroiditis
0.000 0.726 0.274
E06.4 Drug-induced thyroiditis
0.000 0.726 0.274
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.726 0.274
E06.0 Acute thyroiditis
0.000 0.726 0.274
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.729 0.271
M06.9 Rheumatoid arthritis, unspecified
0.000 0.731 0.269
E23.7 Disorder of pituitary gland, unspecified
0.000 0.732 0.268
E28.9 Ovarian dysfunction, unspecified
0.000 0.733 0.267
E28.8 Other ovarian dysfunction
0.000 0.733 0.267
E28.1 Androgen excess
0.000 0.733 0.267
E28.0 Oestrogen excess
0.000 0.733 0.267
E73.9 Lactose intolerance, unspecified
0.001 0.734 0.266
E24.2 Drug-induced Cushing's syndrome
0.000 0.735 0.265
L43.8 Other lichen planus
0.000 0.735 0.265
C83.7 Burkitt's tumour
0.003 0.736 0.260
E06.1 Subacute thyroiditis
0.001 0.739 0.260
E23.2 Diabetes insipidus
0.000 0.741 0.259
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.742 0.258
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.749 0.251
C82.2 Large cell, follicular
0.001 0.749 0.249
E24.9 Cushing's syndrome, unspecified
0.000 0.750 0.249
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.752 0.248
C83.6 Undifferentiated (diffuse)
0.004 0.754 0.242
C83.5 Lymphoblastic (diffuse)
0.004 0.754 0.242
C83.4 Immunoblastic (diffuse)
0.004 0.754 0.242
C83.2 Mixed small and large cell (diffuse)
0.004 0.754 0.242
E85.4 Organ-limited amyloidosis
0.001 0.756 0.244
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.756 0.244
E21.4 Other specified disorders of parathyroid gland
0.000 0.757 0.243
E21.2 Other hyperparathyroidism
0.000 0.757 0.243
E20 Hypoparathyroidism
0.000 0.757 0.243
C82.3 Follicular lymphoma grade IIIa
0.002 0.759 0.239
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.760 0.240
E24.8 Other Cushing's syndrome
0.000 0.762 0.238
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.762 0.238
E24.3 Ectopic ACTH syndrome
0.000 0.762 0.238
E24.1 Nelson's syndrome
0.000 0.762 0.238
E24.0 Pituitary-dependent Cushing's disease
0.000 0.762 0.238
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.004 0.763 0.233
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.764 0.236
E23.1 Drug-induced hypopituitarism
0.000 0.764 0.236
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.001 0.764 0.235
C85.0 Lymphosarcoma
0.001 0.764 0.235
E67 Other hyperalimentation
0.000 0.767 0.233
E68 Sequelae of hyperalimentation
0.000 0.767 0.233
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.006 0.768 0.226
C86 Other specified types of T/NK-cell lymphoma
0.006 0.768 0.226
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.768 0.232
C84 Peripheral and cutaneous T-cell lymphomas
0.004 0.772 0.224
E23.6 Other disorders of pituitary gland
0.000 0.772 0.228
E85.3 Secondary systemic amyloidosis
0.001 0.772 0.227
C85.7 Other specified types of non-Hodgkin's lymphoma
0.001 0.773 0.227
E29 Testicular dysfunction
0.000 0.773 0.227
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.773 0.227
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.774 0.226
C81 Hodgkin's disease
0.004 0.775 0.221
C82.6 Cutaneous follicle centre lymphoma
0.002 0.776 0.222
C82.5 Diffuse follicle centre lymphoma
0.002 0.776 0.222
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.002 0.778 0.220
E23.0 Hypopituitarism
0.000 0.781 0.219
E28.3 Primary ovarian failure
0.000 0.783 0.216
E25.9 Adrenogenital disorder, unspecified
0.000 0.786 0.213
E25.8 Other adrenogenital disorders
0.000 0.786 0.213
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.786 0.213
E30.9 Disorder of puberty, unspecified
0.000 0.786 0.213
E30.8 Other disorders of puberty
0.000 0.786 0.213
E30.1 Precocious puberty
0.000 0.786 0.213
E30.0 Delayed puberty
0.000 0.786 0.213
E31.9 Polyglandular dysfunction, unspecified
0.000 0.786 0.213
E31.8 Other polyglandular dysfunction
0.000 0.786 0.213
E31.1 Polyglandular hyperfunction
0.000 0.786 0.213
E31.0 Autoimmune polyglandular failure
0.000 0.786 0.213
E32.9 Disease of thymus, unspecified
0.000 0.786 0.213
E32.8 Other diseases of thymus
0.000 0.786 0.213
E32.1 Abscess of thymus
0.000 0.786 0.213
E32.0 Persistent hyperplasia of thymus
0.000 0.786 0.213
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.786 0.213
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.786 0.213
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.786 0.213
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.787 0.213
C94 Other leukaemias of specified cell type
0.006 0.787 0.207
C82.0 Small cleaved cell, follicular
0.002 0.788 0.211
C82.4 Follicular lymphoma grade IIIb
0.002 0.793 0.205
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.797 0.202
E63 Other nutritional deficiencies
0.000 0.797 0.202
E50 Vitamin A deficiency
0.000 0.797 0.202
E60 Dietary zinc deficiency
0.000 0.797 0.202
E59 Dietary selenium deficiency
0.000 0.797 0.202
E54 Ascorbic acid deficiency
0.000 0.797 0.202
E52 Niacin deficiency [pellagra]
0.000 0.797 0.202
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.799 0.201
E22 Hyperfunction of pituitary gland
0.000 0.800 0.200
E26.9 Hyperaldosteronism, unspecified
0.000 0.801 0.199
E26.8 Other hyperaldosteronism
0.000 0.801 0.199
E26.1 Secondary hyperaldosteronism
0.000 0.801 0.199
C93 Monocytic leukaemia
0.007 0.802 0.192
E56 Other vitamin deficiencies
0.000 0.802 0.198
C83.1 Small cleaved cell (diffuse)
0.004 0.804 0.192
E58 Dietary calcium deficiency
0.000 0.804 0.195
E11.3 With ophthalmic complications
0.000 0.805 0.195
E51 Thiamine deficiency
0.000 0.811 0.189
E61 Deficiency of other nutrient elements
0.000 0.811 0.189
C81.9 Hodgkin's disease, unspecified
0.001 0.815 0.184
M06.98 Rheumatoid arthritis, unspecified (Other)
0.000 0.816 0.184
C88 Malignant immunoproliferative diseases
0.007 0.818 0.176
E06.3 Autoimmune thyroiditis
0.000 0.818 0.182
E26.0 Primary hyperaldosteronism
0.000 0.821 0.179
K51.9 Ulcerative colitis, unspecified
0.176 0.824 0.000
E20.8 Other hypoparathyroidism
0.000 0.825 0.174
E20.1 Pseudohypoparathyroidism
0.000 0.825 0.174
E20.0 Idiopathic hypoparathyroidism
0.000 0.825 0.174
C91 Lymphoid leukaemia
0.005 0.827 0.169
E06.9 Thyroiditis, unspecified
0.001 0.829 0.170
E65 Localised adiposity
0.000 0.831 0.169
C84.5 Other and unspecified T-cell lymphomas
0.003 0.831 0.166
E67.8 Other specified hyperalimentation
0.000 0.832 0.167
E67.3 Hypervitaminosis D
0.000 0.832 0.167
E67.2 Megavitamin-B6 syndrome
0.000 0.832 0.167
E67.1 Hypercarotenaemia
0.000 0.832 0.167
E67.0 Hypervitaminosis A
0.000 0.832 0.167
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.004 0.833 0.162
C86.5 Angioimmunoblastic T-cell lymphoma
0.004 0.833 0.162
C86.4 Blastic NK-cell lymphoma
0.004 0.833 0.162
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.004 0.833 0.162
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.004 0.833 0.162
C86.1 Hepatosplenic T-cell lymphoma
0.004 0.833 0.162
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.004 0.833 0.162
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.004 0.833 0.162
C96.8 Histiocytic sarcoma
0.004 0.833 0.162
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.004 0.833 0.162
C96.6 Unifocal Langerhans-cell histiocytosis
0.004 0.833 0.162
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.004 0.833 0.162
C96.4 Sarcoma of dendritic cells (accessory cells)
0.004 0.833 0.162
C96.3 True histiocytic lymphoma
0.004 0.833 0.162
C96.2 Malignant mast cell tumour
0.004 0.833 0.162
C96.1 Malignant histiocytosis
0.004 0.833 0.162
C96.0 Letterer-Siwe disease
0.004 0.833 0.162
K51 Ulcerative colitis
0.166 0.834 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.003 0.836 0.160
C84.8 Cutaneous T-cell lymphoma, unspecified
0.003 0.836 0.160
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.003 0.836 0.160
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.003 0.836 0.160
C84.3 Lymphoepithelioid lymphoma
0.003 0.836 0.160
C84.2 T-zone lymphoma
0.003 0.836 0.160
C84.1 Sezary's diease
0.003 0.836 0.160
C84.0 Mycosis fungoides
0.003 0.836 0.161
E29.9 Testicular dysfunction, unspecified
0.000 0.837 0.163
E29.8 Other testicular dysfunction
0.000 0.837 0.163
E29.0 Testicular hyperfunction
0.000 0.837 0.163
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.003 0.838 0.158
C81.3 Lymphocytic depletion
0.003 0.838 0.158
C81.2 Mixed cellularity
0.003 0.838 0.158
C82.1 Mixed small cleaved and large cell, follicular
0.002 0.840 0.158
C81.7 Other Hodgkin's disease
0.003 0.840 0.157
K51.2 Ulcerative (chronic) proctitis
0.158 0.842 0.000
C81.0 Lymphocytic predominance
0.003 0.845 0.152
C95 Leukaemia of unspecified cell type
0.007 0.845 0.148
C84.4 Peripheral T-cell lymphoma
0.003 0.846 0.151
C91.9 Lymphoid leukaemia, unspecified
0.002 0.847 0.151
K51.3 Ulcerative (chronic) rectosigmoiditis
0.153 0.847 0.000
C94.7 Other specified leukaemias
0.005 0.847 0.148
C94.5 Acute myelofibrosis
0.005 0.847 0.148
C94.4 Acute panmyelosis
0.005 0.847 0.148
C94.3 Mast cell leukaemia
0.005 0.847 0.148
C94.2 Acute megakaryoblastic leukaemia
0.005 0.847 0.148
C94.1 Chronic erythraemia
0.005 0.847 0.148
C94.0 Acute erythraemia and erythroleukaemia
0.005 0.847 0.148
K51.5 Mucosal proctocolitis
0.148 0.852 0.000
E50.9 Vitamin A deficiency, unspecified
0.000 0.854 0.145
E50.8 Other manifestations of vitamin A deficiency
0.000 0.854 0.145
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.854 0.145
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.854 0.145
E50.5 Vitamin A deficiency with night blindness
0.000 0.854 0.145
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.854 0.145
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.854 0.145
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.854 0.145
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.854 0.145
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.854 0.145
E63.9 Nutritional deficiency, unspecified
0.000 0.854 0.145
E63.8 Other specified nutritional deficiencies
0.000 0.854 0.145
E63.1 Imbalance of constituents of food intake
0.000 0.854 0.145
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.854 0.145
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.854 0.145
E64.8 Sequelae of other nutritional deficiencies
0.000 0.854 0.145
E64.3 Sequelae of rickets
0.000 0.854 0.145
E64.2 Sequelae of vitamin C deficiency
0.000 0.854 0.145
E64.1 Sequelae of vitamin A deficiency
0.000 0.854 0.145
E64.0 Sequelae of protein-energy malnutrition
0.000 0.854 0.145
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.005 0.855 0.140
E55 Vitamin D deficiency
0.000 0.856 0.144
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.857 0.143
E22.8 Other hyperfunction of pituitary gland
0.000 0.857 0.143

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.